If you are having trouble viewing this email please go to http://www.biocompsystems.com/newsletters/bits/v1n18.htm to view it in your browser. To ensure receipt of our emails, please add profit@biocompsystems.com to your Address Book. Thank you.

   BioComp Systems › Bits Newsletters › Volume 1 Number 18


Dakota R/T Beta Released


The next generation of adaptive trading technologies, Dakota R/T, has been released to select traders as we expand beyond end-of-day to the exciting profit opportunities of intra-day trading.  A limited number of discounted "Early Adopter" Dakota R/T licenses will be available very soon, on a "first come, first served" basis.  Keep tuned to this newsletter and an eye on the Dakota R/T home page.
 
 

New in BioComp Trading Technologies


Dakota Express Price Increase
Dakota Express is the non-scripting version of Dakota end-of-day.  Presently valued at $429, we will be raising that to $499 on Monday, June 26th.  It's a good time to get started with Dakota.
Order
 
Compare Dakota End of Day to Dakota R/T ›
Dakota R/T is not just an upgrade to Dakota End-of-Day, but a significantly different product.  Built for capacity, speed and direct drinking from data fire hoses, Dakota R/T is a new breed based on the success of the end-of-day version.  Compare

 
Make Full Use of Your Computer's Power ›
Multi-processor and multi-core chips are the latest technologies for enhancing computing performance and both BioComp Profit and Dakota are especially designed to deliver on these platforms.  In Dakota, each swarm window runs as a separate process, using its own CPU or "core".  In Profit Professional, you have the ability to model using multiple processors or cores, too.  Profit Pro comes with support for dual processors.  Upgrade your Profit Pro to quad processor for only $75. 
Send an email asking how


Dakota User Successes Climbing

The Dakota "Knowledge Base" provides valuable information not only to users on what trading systems work and which don't for a ticker, but also shows us how well users as a community are doing... Here's some examples that have recently streamed by...
 
User ID Ticker Annual
% Gain
Equity Curve Straightness Trading Bot
         
CAE738... COB 19% 0.811 Polycaster
AA8788... $VXO 109% 0.957 Fisher
AA8788... $VXO 108% 0.965 DSS
C5FF8E... OIH 29% 0.900 DSS
396D0C... ES 10% 0.920 DSS
396D0C... ER2 34% 0.905 DSS_Eq
452B06... FESX 28% 0.954 SlowK
683378... YHOO 137% 0.929 DSS

Gains shown are calculated generally over the last 5 years and equity straightness is how straight and smooth the equity curve is.  If you are over 0.9 you are doing well.  Of course, the usual disclaimers apply and there are no guarantees, but we are seeing a consistent rise in the performance of systems people are building in Dakota, even users that joined us in the last week or two.
 

 

In the Community


Participate in our new BioComp Profit and Dakota forums to share ideas with other users to learn how to make your systems perform best.

Join the Discussion
 ›
 


 
In This Issue
Other Items Of Interest
See Dakota Swarm TechnologyTM  trading systems perform on a variety of securities
You can build your own trading bots for BioComp Dakota using Visual Basic 6.
 

 

Customer Quote
T.B. in California says...
"As other user's have already pointed out, Dakota is fun to use. And simple to use. I don't want to compare Dakota to a charting app but most charting apps are a pain..."
 
Join Us Today !
 
 

This newsletter is brought to you by BioComp Systems, Inc.  Please forward it to anyone who might be interested.  They can also subscribe at: http://www.biocompsystems.com/cgi-bin/mojo.cgi?f=s&l=Profit

These documents are provided for informational purposes only. The information contained in this document represents the current view of BioComp Systems on the material discussed as of the date of publication.  Materials written should not be interpreted to be a commitment on the part of BioComp and BioComp cannot guarantee the accuracy of any information presented after the date of publication.   INFORMATION PROVIDED IN THIS DOCUMENT IS PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND FREEDOM FROM INFRINGEMENT. Statements of equity performance are hypothetical and have not been substantiated by records of actual trading.  Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading.  Also, since the trades have not actually been executed, the results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity.  Simulated trading programs in general are also subject to the fact that they are designed with the benefit of hindsight. No representation is being made that any account will or is likely to achieve profits or losses similar to those mentioned.

The user assumes the entire risk as to the accuracy and the use of this document. This document may be copied and distributed subject to the following conditions: 1) The entire document must be copied without modification; 2) All copies must contain BioComp's copyright notice and any other notices provided therein; and 3) This document may not be distributed for profit.  All trademarks acknowledged.  (C) Copyright BioComp Systems, Inc. 2006.